Hypertension in the neonatal period

Current Opinion in Pediatrics

Volumn 24, Issue 2, 2012, Pages

  Flynn, Joseph T ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular disease; hypertension; infant; neonate; normative data

Indexed keywords

HYPERTENSIVE AGENT;

BIRTH WEIGHT; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CHRONIC LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG SAFETY; GENOTYPE; GESTATIONAL AGE; HEART HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; LONG TERM CARE; MAGNETIC RESONANCE ANGIOGRAPHY; MATERNAL CARE; NEPHRON; NEWBORN; NEWBORN DISEASE; OSCILLOMETRY; OUTCOME ASSESSMENT; POSTNATAL CARE; PRENATAL PERIOD; PRIORITY JOURNAL; REVIEW; SMALL FOR DATE INFANT; UMBILICAL ARTERY CATHETERIZATION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERTENSION; INCIDENCE; INFANT, NEWBORN; REFERENCE VALUES;

EID: 84859084015     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32834f8329     Document Type: Review

References (83)

1. Zubrow AB, Hulman S, Kushner H, et al. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. J Perinatol 1995; 15:470-479.
2. Pejovic B, Peco-Antic A, Marinkovic-Eric J. Blood pressure in noncritically ill preterm and full-term neonates. Pediatr Nephrol 2007; 22:249-257. (Pubitemid 44964326)
3. Kent AL, Meskell S, Falk MC, Shadbolt B. Normative blood pressure data in nonventilated premature neonates from 28-36 weeks gestation. Pediatr Nephrol 2009; 24:141-146.
4. Sadoh WE, Ibhanesehbor SE, Monguno AM, Gubler DJ. Predictors of newborn systolic blood pressure. West African J Med 2010; 29:86-90. Recent study examining influences on BP in newborns, including socioeconomic status.
5. Lurbe E, Garcia-Vicent C, Torro I, et al. First-year blood pressure increase steepest in low birthweight newborns. J Hypertens 2007; 25:81-86. (Pubitemid 44885667)
6. Smal JC, Uiterwaal CS, Bruinse HW, et al. Inverse relationship between birth weight and blood pressure in growth-retarded but not in appropriate for gestational age infants during the first week of life. Neonatology 2009;96:86-92.
7. Been JV, Kornelisse RF, Rours IG, et al. Early postnatal blood pressure in preterm infants: effects of chorioamnionitis and timing of antenatal steroids. Pediatr Res 2009; 66:571-576. Examines the effects of maternal health and other antenatal factors on BP in the newborn period.
8. Mildenhall LF, Battin MR, Morton SM, et al. Exposure to repeat doses of antenatal glucocorticoids is associated with altered cardiovascular status after birth. Arch Dis Child Fetal Neonatal Ed 2006; 91:F56-F60. (Pubitemid 43059204)
9. Mildenhall L, Battin M, Bevan C, et al. Repeat prenatal corticosteroid doses do not alter neonatal blood pressure or myocardial thickness: randomized, controlled trial. Pediatrics 2009; 123:e646-e652. Randomized clinical trial that contradicts earlier studies that suggested that repeat doses of antenatal steroids given for prematurity lead to elevated BP in the newborn period.
10. Kent AL, Shadbolt B, Hu E, et al. Do maternal- orpregnancy-associated disease states affect blood pressure in the early neonatal period? Aust N Z J Obstet Gynaecol 2009; 49:364-370.
11. Dagle JM, Fisher TJ, Haynes SE, et al. Cytochrome P450 (CYP2D6) genotype is associated with elevated systolic blood pressure in preterm infants after discharge from the neonatal intensive care unit. J Pediatr 2011; 159:104-109. Examines potential genetic susceptibility to factors such as antenatal steroid administration, and the subsequent effect on newborn BP.
12. Baum M. Role of the kidney in the prenatal and early postnatal programming of hypertension. Am J Physiol Renal Physiol 2010; 298:F235-F247.
13. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114(2 Suppl 4th Report):555-576.
14. Dionne JM, Abitbol CL, Flynn JT. Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol 2012; 27:17-32. Comprehensive review of hypertension in neonates and older infants, including detailed discussion of normative BP data, evaluation and antihypertensive drug therapy.
15. Dionne JM, Abitbol CL, Flynn JT. Erratum to: Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol 2012; 27:159-160.
16. Kent AL, Kecskes Z, Shadbolt B, Falk MC. Blood pressure in the first year of life in healthy infants born at term. Pediatr Nephrol 2007; 22:1743-1749. (Pubitemid 47337430)
17. Blowey DL, Duda PJ, Stokes P, Hall M. Incidence and treatment of hypertension in the neonatal intensive care unit. J Am Soc Hypertens 2011; 5:478-483. [PMID: 21925997] Utilizes billing/coding data to examine the incidence of hypertension in contemporary NICUs, and also describes current patterns of antihypertensive drug use in neonates.
18. Seliem WA, Falk MC, Shadbolt B, et al. Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatr Nephrol 2007; 22:2081-2087. (Pubitemid 350090715)
19. Barrington KJ. Umbilical artery catheters in the newborn: effects of position of the catheter tip. Cochrane Database Syst Rev 2000(1):CD000505. doi: 10.1002/14651858.CD000505.
20. Boo NY, Wong NC, Zulkifli SS, et al. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Paediatr Child Health 1999; 35:460-465.
21. Lanzarini VV, Furusawa EA, Sadeck L, et al. Neonatal arterial hypertension in nephro-urological malformations in a tertiary care hospital. J Hum Hypertens 2006; 20:679-683. (Pubitemid 44269859)
22. Abman SH, Warady BA, Lum GM, et al. Systemic hypertension in infants with bronchopulmonary dysplasia. J Pediatr 1984; 104:929-931.
23. Anderson AH, Warady BA, Daily DK, et al. Systemic hypertension in infants with severe bronchopulmonary dysplasia: associated clinical factors. Am J Perinatol 1993; 10:190-219.
24. Friedman AL, Hustead VA. Hypertension in babies following discharge from a neonatal intensive care unit. Pediatr Nephrol 1987; 1:30-34. (Pubitemid 18014540)
25. Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 2002; 87:F15-F18. (Pubitemid 34753789)
26. Flynn JT. Neonatal hypertension. In: Flynn JT, Ingelfinger J, Portman R, editors. Pediatric hypertension. 2nd ed. New York, NY: Humana Press Inc.; 2011. pp. 375-396.
27. Butt W, Whyte H. Blood pressure monitoring in neonates: comparison of umbilical and peripheral artery catheter measurements. J Pediatr 1984; 105:630-632. (Pubitemid 14003584)
28. Weindling AM. Blood pressure monitoring in the newborn. Arch Dis Child 1989; 64:444-447. (Pubitemid 19105085)
29. Low JA, Panagiotopoulos C, Smith JT, et al. Validity of newborn oscillometric blood pressure. Clin Invest Med 1995; 18:163-167.
30. Dannevig I, Dale H, Liestol K, et al. Blood pressure in the neonate: three noninvasive oscillometric pressure monitors compared with invasively measured blood pressure. Acta Pediatr 2005; 94:191-196. (Pubitemid 40343694)
31. O'Shea J, Dempsey E. A comparison of blood pressure measurements in newborns. Am J Perinatol 2009; 26:113-116. Questions the validity of BP obtained using oscillometric methods.
32. Nwankwo M, Lorenz J, Gardiner J. A standard protocol for blood pressure measurement in the newborn. Pediatrics 1997; 99:E10.
33. Crossland DS, Furness JC, Abu-Harb M, et al. Variability of four limb blood pressure in normal neonates. Arch Dis Child Fetal Neonatal Ed 2004; 89:F325-F327. (Pubitemid 38869674)
34. Proesmans W, van de Wijdeven P, Van Geet C. Thrombophilia in neonatal renal venous and arterial thrombosis. Pediatr Nephrol 2005; 20:241-242. (Pubitemid 40178735)
35. Tannenbaum J, Hulman S, Falkner B. Relationship between plasma renin concentration and atrial natriuretic peptide in the human newborn. Am J Perinatol 1990; 7:174-177. (Pubitemid 20138169)
36. Krüger C, Rauh M, Dörr HG. Immunoreactive renin concentration in healthy children from birth to adolescence. Clin Chim Acta 1998; 274:15-27. (Pubitemid 28243260)
37. Vehaskari VM. Heritable forms of hypertension. Pediatr Nephrol 2009; 24:1929-1937.
38. Kiessling SG, Wadhwa N, Kriss VM, et al. An unusual case of severe therapyresistant hypertension in a newborn. Pediatrics 2007; 119:e301-e304. (Pubitemid 46397851)
39. Elsaify WM. Neonatal renal vein thrombosis: grey-scale and Doppler ultrasonic features. Abdom Imaging 2009; 34:413-418.
40. Roth CG, Spottswood SE, Chan JC, et al. Evaluation of the hypertensive infant: a rational approach to diagnosis. Radiol Clin North Am 2003; 41:931-944. (Pubitemid 37152084)
41. Mustafa AE, Bloom DA, Valentini RP, et al. MR angiography in the evaluation of a renovascular cause of neonatal hypertension. Pediatr Radiol 2006; 36:158-161.
42. Tullus K, Brennan E, Hamilton G, et al. Renovascular hypertension inchildren. Lancet 2008; 371:1453-1463.
43. James L, Ito S. Neonatal pharmacology: rational therapeutics for the most vulnerable. Clin Pharmacol Ther 2009; 86:573-577. Highlights the need for more extensive drug testing in neonates.
44. Flynn JT, Tullus K. Severe hypertension inchildren and adolescents: pathophysiology and treatment. Pediatr Nephrol 2009; 24:1101-1112.
45. O'Dea RF, Mirkin BL, Alward CT, et al. Treatment of neonatal hypertension with captopril. J Pediatr 1988; 113:403-406.
46. Tack ED, Perlman JM. Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 1988; 112:805-810.
47. Guron G, Friberg P. An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 2000; 18:123-137. (Pubitemid 30114057)
48. Liaw JJ, Portman RJ, Hixson CJ, et al. Juvenile toxicity assessment of irbesartan in rats: comparison of neonatal versus weanling dose initiation [abstract]. Pediatric Academic Societies 2011. http://www.abstracts2view.com/ pas.
49. Rajpoot DK, Duel B, Thayer K, Shanberg A. Medically resistant neonatal hypertension: revisiting the surgical causes. J Perinatol 1999; 19:582-583.
50. Bendel-Stenzel M, Najarian JS, Sinaiko AR. Renal artery stenosis: long-term medical management before surgery. Pediatr Nephrol 1995; 10:147-151.
51. Greenberg R, Waldman D, Brooks C, et al. Endovascular treatment of renal artery thrombosis caused by umbilical artery catheterization. J Vasc Surg 1998; 28:949-953. (Pubitemid 28521037)
52. Webb NJA, Lewis MA, Bruce J, et al. Unilateral multicystic dysplastic kidney: the case for nephrectomy. Arch Dis Child 1997; 76:31-34. (Pubitemid 27060488)
53. Adelman RD. Long-term follow-up of neonatal renovascular hypertension. Pediatr Nephrol 1987; 1:35-41. (Pubitemid 18014541)
54. Caplan MS, Cohn RA, Langman CB, et al. Favorable outcome of neonatal aortic thrombosis and renovascular hypertension. J Pediatr 1989; 115:291-295. (Pubitemid 19190357)
55. Mackenzie HS, Lawler EV, Brenner BM. Congenital oligonephropathy: the fetal flaw in essential hypertension? Kidney Int 2006; 55:S30-S34.
56. Keller G, Zimmer G, Mall G, et al. Nephron number in patients with primary hypertension. N Engl J Med 2003; 348:101-108. (Pubitemid 36056716)
57. Baartmans MGA, Dokter J, den Hollander C, Kroon AA, et al. Use of skin Substitute Dressings in the Treatment of Staphylococcal Scalded Skin Syndrome in Neonates and Young Infants. Neonatology 2011; 100:9-13.
58. Been JV, Kornelisse RF, Rours IG, et al. Early postnatal blood pressure in preterm infants: effects of chorioamnionitis and timing of antenatal steroids. Pediatr Res 2009; 66:571-576. [07]
59. Blowey DL, Duda PJ, Stokes P, Hall M. Incidence and treatment of hypertension in the neonatal intensive care unit. J Am Soc Hypertens 2011; 5:478-483. [PMID: 21925997] [17]
60. Cass DL. Impact of prenatal diagnosis and therapy on neonatal surgery. Semin Fetal Neonatal Med 2011; 16:130-138.
61. Chapados I, Lee TF, Chik CL, Cheung PY. Hydrocortisone administration increases pulmonary artery pressure in asphyxiated newborn piglets reoxygenated with 100% oxygen. Eur J Pharmacol 2011; 652:111-116.
62. Couture A, Baud C, Prodhomme O, Saguintaah M, et al. Ultrasound of the neonatal hip: Initial evaluation and follow-up [French]. J Radiol 2011; 92:142-165.
63. Dagle JM, Fisher TJ, Haynes SE, et al. Cytochrome P450 (CYP2D6) genotype is associated with elevated systolic blood pressure in preterm infants after discharge from the neonatal intensive care unit. J Pediatr 2011; 159:104-109. [11]
64. de la Roque ED, Storme L, Mauriat P, Bonnet S. Pulmonary hypertension in pediatric and neonatal intensive care unit. Part II: Diagnosis and treatment [French]. Arch Pediatr 2011; 18:195-203.
65. Di Blasi RM, Myers TR, Hess DR. Evidence-Based Clinical Practice Guideline: Inhaled Nitric Oxide for Neonates With Acute Hypoxic Respiratory Failure. Respiratory Care 2010; 55:1717-1745.
66. Dionne JM, Abitbol CL, Flynn JT. Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol 2012; 27:17-32. [14]
67. Finer NN, Kinsella JP. Neonatal intensive care perspective. In: Pediatric Critical Care Med 2011; 12:S62-S65.
68. Huddle KRL. Phaeochromocytoma in black South Africans - a 30-year audit. S Afr Med J 2011; 101:184-188.
69. James L, Ito S. Neonatal pharmacology: rational therapeutics for the most vulnerable. Clin Pharmacol Ther 2009; 86:573-577. [43]
70. Kordek A, Torbe A, Podraza W, Loniewska B, et al. Does prenatal antibiotic therapy compromise the diagnosis of early-onset infection and management of the neonate?.. J Perinat Med 2011; 39:337-342.
71. Landon MB, Mele L, Spong CY, Carpenter MW, et al. The Relationship Between Maternal Glycemia and Perinatal Outcome. Obstet Gynecol 2011; 117:218-224.
72. McQuilten ZK, Wood EM, Savoia H, Cole S. A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry [Review]. Aust N Z J Obstet Gynaecol 2011; 51:191-198.
73. Merritt C, Feit LR, Valente JH. A Neonate With High-Outflow Congestive Heart Failure and Pulmonary Hypertension Due to an Intracranial Arteriovenous Malformation. Pediatr Emerg Care 2011; 27:645-648.
74. Mildenhall L, Battin M, Bevan C, et al. Repeat prenatal corticosteroid doses do not alter neonatal blood pressure or myocardial thickness: randomized, controlled trial. Pediatrics 2009; 123:e646-e652. [09]
75. O'Shea J, Dempsey E. A comparison of blood pressure measurements in newborns. Am J Perinatol 2009; 26:113-116. [31]
76. Ramachandrappa A, Rosenberg ES, Wagoner S, Jain L. Morbidity and Mortality in Late Preterm Infants with Severe Hypoxic Respiratory Failure on Extra-Corporeal Membrane Oxygenation. J Pediatr 2011; 159:192-198.
77. Ruano R, Duarte SA, Pimenta EJD, Takashi E, et al. Comparison between Fetal Endoscopic Tracheal Occlusion Using a 1.0-mm Fetoscope and Prenatal Expectant Management in Severe Congenital Diaphragmatic Hernia [Review]. Fetal Diagn Ther 2011; 29:64-70.
78. Rubio-Cabezas O, Klupa T, Malecki MT. Permanent neonatal diabetes mellitus - the importance of diabetes differential diagnosis in neonates and infants [Review]. Eur J Clin Invest 2011; 41:323-333.
79. Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: integrating clues from the bench and bedside [Review]. Eur J Clin Invest 2011; 41:672-678.
80. & Sadoh WE, Ibhanesehbor SE, Monguno AM, Gubler DJ. Predictors of newborn systolic blood pressure. West African J Med 2010; 29:86-90. [04]
81. Thaler M, Biedermann R, Lair J, Krismer M, et al. Cost-effectiveness of universal ultrasound screening compared with clinical examination alone in the diagnosis and treatment of neonatal hip dysplasia in Austria. J Bone Joint Surg-Br Vol 2011; 93B:1126-1130.
82. Thomas CA, Moffett BS,Wagner JL, Mott AR, et al. Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. In: Pediatric Critical Care Med 2011; 12:28-32.
83. Yonkers KA, Vigod S, Ross LE. Diagnosis, Pathophysiology, and Management of Mood Disorders in Pregnant and Postpartum Women. Obstet Gynecol 2011; 117:961-977.